Examples of 'anti-platelet' in a sentence
Meaning of "anti-platelet"
anti-platelet (adjective) - Anti-platelet refers to substances or medications that inhibit the aggregation of platelets in the blood, commonly used for preventing blood clots
How to use "anti-platelet" in a sentence
Basic
Advanced
anti-platelet
The preferred anti-platelet agent is aspirin.
This belongs to a group of medicines called anti-platelet medicines.
The preferred anti-platelet drug is aspirin.
O prevent blood clot or any mention of anti-platelet action.
Aspirin is an anti-platelet agent that prevents clotting.
Adjunctive therapies include anticoagulant and anti-platelet therapies.
Three anti-platelet drugs used in combination are safe.
O may also be a marker of anti-platelet resistance.
Kengrexal is an anti-platelet medicine that contains the active substance cangrelor.
A preferred second agent is at least one anti-platelet agent.
Especially preferred anti-platelet agents are aspirin and clopidogrel.
Pharmacotherapy includes both anticoagulant and anti-platelet drugs.
The prescription of anti-platelet aggregation medical treatment is the rule.
A further component of the present invention is preferably an anti-platelet drug.
In an exemplary embodiment, the anti-platelet agent is heparin or a prodrug of heparin.
See also
Anti-platelet agents are commonly used in the prevention of acute cardiovascular events.
Hematuria is not related to the use of anti-platelet agents or NSAIDs.
Anti-coagulants and anti-platelet agents are frequently used to alleviate thrombosis.
A potential complication is the possibility of the individual producing anti-platelet antibodies.
Perhaps using dual anti-platelet therapy prevents other vascular events.
Its anti-inflammatory action is weak and it has practically no anti-platelet effect.
New study to examine genomics of anti-platelet therapy after coronary interventions.
Other anti-platelet glycoprotein antibodies exist but are much less frequent.
However, no such bicyclic compounds have been reported to have anti-platelet activity.
Anti-platelet agents can include drugs such as aspirin and dipyridamole.
Levels of platelet miRNAs were measured before and after anti-platelet therapy.
The anti-platelet antibodies opsonize the platelets, leading to destruction by macrophages.
An example of such an agent is heparin but could be any anticoagulant or anti-platelet.
The anti-platelet aggregation activity of said derivatives was determined on human platelets.
They affect the mechanism of clotting differently than anti-platelet medications.
Additional anti-platelet therapy utilised in the study included aspirin and clopidogrel.
Identification of thrombosis or bleeding risk in an individual with and without anti-platelet therapy.
Anticoagulants and anti-platelet agents are amongst the most commonly used medications.
These are preferred to achieve the beneficial effects of aspirin, especially anti-platelet activity.
The anti-platelet activity of cilostazol also raised a concern for haemorrhagic events.
The standard may also contain anti-platelet agents and coagulation inhibitors.
Its anti-platelet activity proves to be a boon for patients of deep vein thrombosis.
The specific indication for the anti-platelet agent in each subject was not known.
Anti-platelet drugs make these cells less sticky and less likely to clot.
Predictably, the major adverse effect of anti-platelet drugs such as aspirin is excessive bleeding.
Additional anti-platelet therapy utilised in the study included acetylsalicylic acid and clopidogrel.
Megakaryocytes are identified by staining with specific anti-platelet antigen antibodies and counted microscopically.
Other suitable anti-platelet agents include ticlopidine, including pharmaceutically acceptable salts or prodrugs thereof.
It must be stated that diclofenac and ibuprofen have a relatively weak anti-platelet activity.
In one instance, the anti-platelet agent is a heparin analog or a prodrug of a heparin analog.
In this respect, prostacyclin has been shown to possess vasodilatory and anti-platelet aggregation activities.
Other associations of anti-platelet aggregation agents with aspirin have been described in the literature.
As medical treatment with drugs after cardiovascular angioplasty, anti-platelet agents are often used.
Certain antibodies with anti-platelet activity have also been used to alleviate various thromboses.
The new format is now suitable as an antibody screening test for anti-platelet antibodies.
